89BIO, INC. (ETNB): Price and Financial Metrics
ETNB Price/Volume Stats
Current price | $9.29 | 52-week high | $16.63 |
Prev. close | $9.14 | 52-week low | $6.88 |
Day low | $8.87 | Volume | 1,182,800 |
Day high | $9.52 | Avg. volume | 941,926 |
50-day MA | $8.11 | Dividend yield | N/A |
200-day MA | $9.13 | Market Cap | 913.99M |
ETNB Stock Price Chart Interactive Chart >
89BIO, INC. (ETNB) Company Bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
ETNB Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...